Businesswire  | 
aufrufe Aufrufe: 111

AstroNova Reports Fourth-Quarter and Full-Year Fiscal 2026 Financial Results

AstroNova, Inc. (Nasdaq: ALOT), a leading innovator in specialized print technology solutions, today announced financial results for its fiscal 2026 fourth quarter and full-year ended January 31, 2026.

play Anhören
share Teilen
feedback Feedback
copy Kopieren
newsletter
font_big Schrift vergrößern
Mann mit Smartphone und Tablet (Symbolbild).
Quelle: - © metamorworks / iStock / Getty Images Plus / Getty Images:
AstroNova Inc 13,64 $ AstroNova Inc Chart +0,29%
Zugehörige Wertpapiere:

Jorik Ittmann, President and Chief Executive Officer of AstroNova, stated, "The second half of fiscal 2026 was a reset period for AstroNova. As we began the year, we recognized that the changes we were making in the business would begin to be realized with a stronger second half. Our focus was on stabilizing the business and ending the year having generated more cash, reduced debt, and raised accountability across both segments. Our Aerospace business delivered a strong performance, with ToughWriter now representing more than 80% of total flight deck printer shipments, positioning us well as aircraft build rates increase.

“In Product ID, we provide label printing solutions that address the needs of three key verticals: healthcare/life sciences, industrial and chemical industries. In these markets our labels are a component of customers’ products and are critical to their success. Our restructuring efforts are being realized through improving commercial momentum in these verticals. We have employed more robust analytics to understand our customers and markets and are better directing our resources to drive growth. This includes continuing to evolve the team, putting the right talent in the correct roles, and recognizing where and why we can win. We expect this focus of our resources where we have competitive advantages will lead to stronger, more profitable growth."

Mr. Ittmann added, "Looking ahead to fiscal 2027, we expect Aerospace to deliver measured growth, supported by rising aircraft production, a favorable product mix, and the expiration of a major royalty obligation during the third quarter of the year that negatively impacts gross margin on an annualized basis by approximately $2 million. In Product ID, we are focused on converting our commercial pipeline into consistent revenue growth while strengthening operational performance. We believe we can create greater value for our shareholders with our enhanced product offerings, go-to-market strategy and operational restructuring. Importantly, we will evaluate all strategic alternatives to achieve this goal."

Fourth Quarter Fiscal 2026 Overview1 (comparisons are to the prior-year period unless noted otherwise)

 
Three Months Ended 2H Fiscal 2026 compared with 1H Fiscal 2026
January 31,
2026
January 31,
2025
$
Variance
%
Variance
2H FY26 1H FY26 $
Variance
%
Variance
Revenue

37,536

37,361

175

0.5%

76,705

73,810

2,895

3.9%

Gross Profit

11,325

12,226

(901)

(7.4)%

24,769

22,865

1,902

8.3%

Gross Profit Margin

 

30.2%

 

32.7%

 

32.3%

 

31.0%

Non-GAAP Gross Profit

11,903

12,289

(386)

(3.1)%

25,707

23,264

2,444

10.5%

Non-GAAP Gross Profit Margin

 

31.7%

 

32.9%

 

33.5%

 

31.5%

Operating Income (Loss)

56

(12,311)

12,367

(100.5)%

1,342

(137)

1,479

N/A

Operating Margin

 

0.1%

 

(33.0)%

 

1.7%

 

(0.2)%

Non-GAAP Operating Income

1,124

1,408

(284)

(20.2)%

3,688

1,906

1,781

93.4%

Non-GAAP Operating Income Margin

 

3.0%

 

3.8%

 

4.8%

 

2.6%

Net Income (Loss)

(1,134)

(15,600)

14,466

(92.7)%

(756)

(1,620)

864

53.3%

Non-GAAP Net Income (Loss)

(305)

419

(724)

(172.7)%

1,277

(59)

1,336

N/A

Adjusted EBITDA

3,306

2,794

512

18.3%

7,478

5,202

2,276

43.7%

Adjusted EBITDA Margin

 

8.8%

 

7.5%

 

9.7%

 

7.0%

______________________________ 

1 Non-GAAP gross profit, Non-GAAP gross profit margin, Non-GAAP operating income, Non-GAAP operating income margin, Non-GAAP net income, adjusted EBITDA and adjusted EBITDA margin are Non-GAAP financial measures.  Refer to the reconciliation of GAAP to non-GAAP measures in the tables that accompany this news release.

Compared with the prior-year period, revenue increased $0.2 million as growth in Product ID slightly exceeded lower Aerospace revenue. Tariff mitigation contributed $0.6 million in revenue and foreign currency translation was a $0.8 million benefit in the quarter.

As a result of lower volume and mix, gross profit decreased $0.9 million, or 7.4%, and gross margin contracted 250 basis points compared with the prior-year period. On an adjusted basis, gross margin contracted 120 basis points from the prior-year period to 32.9%.

Operating expenses in the quarter were $11.3 million down from $25.0 million in the prior-year period. The prior year period included a goodwill impairment charge of $13.4 million. Operating income for the quarter was $56 thousand compared with operating loss of $12.3 million in the prior-year period, while non-GAAP operating income was $1.1 million, down $0.3 million compared with the prior-year period.

Interest expense of $0.9 million was nominally unchanged from the prior-year period. Net loss of $1.1 million, or $0.15 per share, compared with net loss of $15.6 million in the prior-year period, which included a goodwill impairment charge of $13.4 million. Non-GAAP net loss was $0.3 million, or $0.04 per share. Adjusted EBITDA was $3.3 million and Adjusted EBITDA margin was 8.8%.

Beginning in the fourth quarter of fiscal 2026, the Company revised its segment reporting methodology to allocate related general and administrative expenses directly to the reportable segments, Product Identification and Aerospace. Management believes this change better reflects the true operating performance of each segment. Prior period segment results have been recast to reflect this change. The impact of this reallocation on segment operating income is presented in the segment tables that follow.

Product Identification (Product ID) Segment Review

Product ID revenue was $26.3 million for the fourth quarter of fiscal 2026, up 2.5%, or $0.7 million, compared with the prior year. Aftermarket revenue remained strong, representing approximately 80% of total segment sales.

Product ID segment operating loss was $0.2 million, an improvement from the segment operating loss of $13.1 million in the prior-year period which included the previously mentioned goodwill impairment charge. Non-GAAP segment operating loss was $0.1 million, or -0.5% of revenue.

Aerospace Segment Review

Aerospace segment revenue was $11.2 million in the fiscal 2026 fourth quarter, a decrease of 4.1%, or $0.5 million from the prior-year, primarily as a result of the timing of projects.

Despite lower sales, Aerospace segment operating profit was $2.3 million, up $0.5 million, or 24.0%, over the prior-year period as a result of improved mix.

Balance Sheet and Cash Flow

Cash from operations in the fourth quarter of fiscal 2026 was $3.7 million and was $11.7 million year to date. The improvement in cash generation in the quarter was primarily the result of reduced working capital requirements, primarily due to lower inventory.

Capital expenditures in the quarter were $139 thousand and $332 thousand for fiscal 2026 compared with $79 thousand and $1.2 million, respectively, in the prior year.

Cash at the end of the fourth quarter of fiscal 2026 was $4.1 million, down $0.9 million from the end of fiscal 2025. Debt as of January 31, 2026 was $37.6 million compared with $46.7 million as of January 31, 2025.

Bookings and Backlog by Segment

Orders in the quarter for the Product ID segment were $27.5 million, up $2.9 million compared with the prior-year period as the Company’s new go-to-market strategy gained traction. The book-to-bill ratio for the segment was 104% and backlog at the end of fiscal 2026 was $13.5 million.

Orders in the quarter for the Aerospace segment were $13.6 million for a book-to-bill ratio of 122% reflecting demand from OEMs for new-build aircraft. Backlog at the end of fiscal 2026 was $12.0 million.

Fiscal 2027 Outlook

“We are making solid progress with the improvement in our Product ID segment and are delivering on the potential of the Aerospace segment. As noted previously, a major royalty obligation for Aerospace will expire in the third quarter this year that will provide an annualized contribution to gross profit of approximately $2 million beginning in the fourth quarter. We are encouraged with our progress and believe we are creating greater opportunity for the business,” concluded Mr. Ittmann.

For fiscal 2027, AstroNova expects mid-single digit revenue growth and expanded adjusted EBITDA margin.

Earnings Conference Call Information

AstroNova will host a conference call and webcast at 8:30 a.m. ET on Tuesday, April 14, 2026, to review financial and operating results for the fourth quarter and full year of fiscal 2026. A question and answer session will follow.

To access the conference call, please dial (201) 689-8560 or find the webcast and accompanying slide presentation at https://investors.astronovainc.com/investors/events-and-presentations/default.aspx.

A telephonic replay will be available from 12:00 p.m. ET on the day of the call through Tuesday, April 28, 2026. To listen to the archived call, dial (412) 317-6671 and enter a replay PIN 13759000. The webcast replay will be available on the Investor Relations section of the Company’s website where a transcript will be posted once available.

About AstroNova, Inc.

AstroNova (Nasdaq: ALOT) is a global provider of printing technologies serving regulated and industrial markets. The Company designs, manufactures, distributes, and services solutions that enable customers to identify, track, and communicate essential product and safety information across a wide range of applications and media. AstroNova supports customers by enabling safety, accuracy and durability for flight deck communications, medical device and healthcare products, essential chemical products, and mission-critical industrial components, while ensuring compliance with local and regional regulatory requirements.

The Product Identification segment delivers end-to-end marking and identification solutions, including hardware, software, and consumables for OEMs, commercial printers, and brand owners. These solutions are used across labels, flexible packaging, corrugated, and industrial substrates, where durability, traceability, and compliance are essential. The Aerospace segment is a global leader in providing products designed for airborne printing solutions, avionics, and data acquisition, including flight deck printing solutions, networking hardware, and specialized aerospace-grade supplies. For more information please visit: www.astronovainc.com.

Use of Non-GAAP Financial Measures
In addition to financial measures prepared in accordance with generally accepted accounting principles (GAAP), this news release contains the Non-GAAP financial measures: Non-GAAP gross profit, Non-GAAP gross profit margin, Non-GAAP operating expenses, Non-GAAP operating income, Non-GAAP operating income margin, Non-GAAP net income (loss), Non-GAAP net income per Common Share - diluted, Non-GAAP segment gross profit, Non-GAAP segment gross profit margin, Non-GAAP segment operating income, Non-GAAP segment operating margin, Adjusted EBITDA and Adjusted EBITDA Margin. AstroNova believes that the inclusion of these Non-GAAP financial measures helps investors gain a meaningful understanding of changes in the Company’s core operating results and can help investors who wish to make comparisons between AstroNova and other companies on both a GAAP and a Non-GAAP basis. AstroNova’s management uses these Non-GAAP financial measures, in addition to GAAP financial measures, as the basis for measuring its core operating performance and comparing such performance to that of prior periods and to the performance of its competitors. These measures are also used by the Company’s management to assist with their financial and operating decision-making. Please refer to the financial reconciliation table included in this news release for a reconciliation of the Non-GAAP measures to the most directly comparable GAAP measures for the three months ended January 31, 2026 and 2025 as well as the years ended January 31, 2026 and 2025.

Forward-Looking Statements
Information included in this news release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical fact but rather reflect our current expectations concerning future events and results. These statements may include the use of the words “believes,” “expects,” “intends,” “plans,” “anticipates,” “likely,” “continues,” “may,” “will,” and similar expressions to identify forward-looking statements. Such forward-looking statements, including those concerning the Company’s anticipated performance, involve risks, uncertainties and other factors, some of which are beyond our control, which may cause our actual results, performance or achievements to be materially different from those expressed or implied by such forward-looking statements. These risks, uncertainties and factors include, but are not limited to, (i) the risk that our efforts to improve sales in our Product Identification segment may not result in the benefits we expect, (ii) the risk that our Aerospace customers may not continue to convert to our ToughWriter® printer in the volumes or on the schedule that we expect; (iii) the risk that we may not realize the anticipated benefits of our next-generation print engine technology; and (iv) those factors set forth in the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2025 and subsequent filings AstroNova makes with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. The reader is cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this news release.

ASTRONOVA, INC.
Condensed Consolidated Statements of Income (Loss)

(In thousands, except per share data)

(Unaudited)

   
Three Months Ended
January 31,
2026
January 31,
2025
$ Variance % Variance
Revenue

$

37,536

 

37,361

 

175

 

0.5

Cost of Revenue

 

26,211

 

 

25,135

 

 

1,076

 

4.3

Gross Profit

 

11,325

 

 

12,226

 

 

(901

(7.4

Total Gross Profit Margin

 

30.2

%

 

32.7

%

Operating Expenses:
Selling & Marketing

 

5,642

 

 

6,097

 

 

(455

(7.5

Research & Development

 

1,797

 

 

1,617

 

 

180

 

11.1

General & Administrative

 

3,830

 

 

3,420

 

 

410

 

12.0

Goodwill Impairment

 

 

 

13,403

 

 

(13,403

(100.0

Total Operating Expenses

 

11,269

 

 

24,537

 

 

(13,268

(54.1

Operating Income (Loss)

 

56

 

 

(12,311

 

12,367

 

(100.5

Total Operating Margin

 

0.1

%

 

(33.0

)%

Interest Expense

 

894

 

 

847

 

 

47

 

5.5

Other (Income)/Expense, net

 

(51

)

 

100

 

 

(151

(151.0

Income (Loss) Before Taxes

 

(788

)

 

(13,258

 

12,470

 

(94.1

Income Tax Provision (Benefit)

 

346

 

 

2,342

 

 

(1,996

(85.2

Net Income (Loss)

$

(1,134

)

(15,600

14,466

 

(92.7

Net Income (Loss) per Common Share - Basic

$

(0.15

)

(2.07

Net Income (Loss) per Common Share - Diluted

$

(0.15

)

(2.07

 
Weighted Average Number of Common Shares - Basic

 

7,653

 

 

7,534

 

Weighted Average Number of Common Shares - Diluted

 

7,653

 

 

7,534

 

Twelve Months Ended
January 31,
2026
January 31,
2025
$ Variance % Variance
Revenue

$

150,515

 

151,283

 

(768

(0.5

Cost of Revenue

 

102,881

 

 

100,625

 

 

2,256

 

2.2

Gross Profit

 

47,634

 

 

50,658

 

 

(3,024

(6.0

Total Gross Profit Margin

 

31.6

%

 

33.5

%

Operating Expenses:
Selling & Marketing

 

22,963

 

 

24,252

 

 

(1,289

(5.3

Research & Development

 

6,788

 

 

6,047

 

 

741

 

12.3

General & Administrative

 

16,380

 

 

15,596

 

 

784

 

5.0

Goodwill Impairment

 

297

 

 

13,403

 

 

(13,106

(97.8

Total Operating Expenses

 

46,428

 

 

59,298

 

 

(12,870

(21.7

Operating Income (Loss)

 

1,206

 

 

(8,640

 

9,846

 

(114.0

Total Operating Margin

 

0.8

%

 

(5.7

)%

Interest Expense

 

3,503

 

 

3,210

 

 

293

 

9.1

Other (Income)/Expense, net

 

239

 

 

437

 

 

(198

(45.3

Income (Loss) Before Taxes

 

(2,536

)

 

(12,287

 

9,751

 

(79.4

Income Tax Provision (Benefit)

 

(160

)

 

2,202

 

 

(2,362

(107.3

Net Income (Loss)

$

(2,376

)

(14,489

12,113

 

(83.6

Net Income (Loss) per Common Share - Basic

$

(0.31

)

(1.93

Net Income (Loss) per Common Share - Diluted

$

(0.31

)

(1.93

 
Weighted Average Number of Common Shares - Basic

 

7,614

 

 

7,509

 

Weighted Average Number of Common Shares - Diluted

 

7,614

 

 

7,509

 

ASTRONOVA, INC.

Condensed Consolidated Balance Sheets

(In thousands)

(Unaudited)

 
January 31,
2026
January 31,
2025
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents

$

4,072

 

5,050

 

Accounts Receivable, net

 

18,985

 

 

21,218

 

Inventories, net

 

43,252

 

 

47,894

 

Prepaid Expenses and Other Current Assets

 

4,395

 

 

3,855

 

Total Current Assets

 

70,704

 

 

78,017

 

PROPERTY, PLANT AND EQUIPMENT

 

40,400

 

 

58,613

 

Less Accumulated Depreciation

 

(26,272

)

 

(42,820

Property, Plant and Equipment, net

 

14,128

 

 

15,793

 

OTHER ASSETS
Identifiable Intangibles, net

 

21,496

 

 

23,519

 

Goodwill

 

17,376

 

 

16,361

 

Deferred Tax Assets, net

 

9,831

 

 

8,431

 

Right of Use Asset

 

2,466

 

 

1,781

 

Other Assets

 

1,565

 

 

1,693

 

TOTAL ASSETS

$

137,566

 

145,595

 

LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES
Accounts Payable

$

6,806

 

7,928

 

Accrued Compensation

 

4,390

 

 

3,745

 

Other Accrued Expenses

 

4,702

 

 

4,461

 

Revolving Line of Credit

 

16,273

 

 

20,929

 

Current Portion of Long-Term Debt

 

3,033

 

 

6,110

 

Short-Term Debt

 

-

 

 

581

 

Current Liability – Royalty Obligation

 

1,656

 

 

1,358

 

Current Liability – Excess Royalty Payment Due

 

331

 

 

691

 

Income Taxes Payable

 

691

 

 

 

Deferred Revenue

 

489

 

 

543

 

Total Current Liabilities

 

38,371

 

 

46,346

 

NON-CURRENT LIABILITIES
Long-Term Debt, net of current portion

 

18,295

 

 

19,044

 

Lease Liabilities, net of current portion

 

1,953

 

 

1,535

 

Grant Deferred Revenue

 

899

 

 

1,090

 

Royalty Obligation, net of current portion

 

145

 

 

1,106

 

Income Tax Payables

 

800

 

 

684

 

Deferred Tax Liabilities

 

-

 

 

40

 

Other Long-Term Liability

 

241

 

 

 

TOTAL LIABILITIES

 

60,704

 

 

69,845

 

SHAREHOLDERS’ EQUITY
Common Stock

 

554

 

 

547

 

Additional Paid-in Capital

 

66,329

 

 

64,215

 

Retained Earnings

 

47,004

 

 

49,380

 

Treasury Stock

 

(35,227

)

 

(35,043

Accumulated Other Comprehensive Loss, net of tax

 

(1,798

)

 

(3,349

TOTAL SHAREHOLDERS’ EQUITY

 

76,862

 

 

75,750

 

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

$

137,566

 

145,595

 

ASTRONOVA, INC.

Condensed Consolidated Statements of Cash Flow – Three Months

(In thousands)

(Unaudited)

  
Three Months Ended
January 31, 2026 January 31, 2025
Cash Flows from Operating Activities:
Net Income (Loss)

$

(1,134

)

(15,599

Adjustments to Reconcile Net Income (Loss) to Net Cash Provided by Operating Activities:
Depreciation and Amortization

 

1,379

 

 

1,266

 

Grant Income Included in Depreciation

 

155

 

 

51

 

Goodwill Impairment

 

-

 

 

13,403

 

Amortization of Debt Issuance Costs

 

10

 

 

8

 

Share-Based Compensation

 

751

 

 

219

 

Deferred Income Tax Provision (Benefit)

 

(1,238

)

 

874

 

Loss on Disposal of Fixed Assets

 

3

 

 

 

Changes in Assets and Liabilities:
Accounts Receivable

 

1,566

 

 

1,240

 

Inventories

 

2,129

 

 

236

 

Income Taxes

 

1,764

 

 

630

 

Accounts Payable and Accrued Expenses

 

(758

)

 

(8

Deferred Revenue

 

(519

)

 

(440

Other

 

(434

)

 

645

 

Net Cash Provided by Operating Activities

$

3,673

 

2,525

 

 
Cash Flows from Investing Activities:
Proceeds from Sale of Equipment

 

13

 

 

 

Purchases of Property, Plant and Equipment

 

(139

)

 

(79

Cash Paid for MTEX Acquisition, net of cash acquired

 

-

 

 

 

Net Cash Used for Investing Activities

$

(126

)

(79

 
Cash Flows from Financing Activities:
Net Cash Proceeds from Employee Stock Option Plans

 

-

 

 

 

Net Cash Proceeds from Share Purchases under Employee Stock Purchase Plan

 

-

 

 

48

 

Net Cash Used for Payment of Taxes Related to Vested Restricted Stock

 

(1

)

 

(18

Revolving Credit Facility, net

 

(1,981

)

 

734

 

Proceeds from Long Term Debt Borrowings

 

-

 

 

 

Payment of Minimum Guarantee Royalty Obligation

 

(279

)

 

(655

Principal Payments of Long-Term Debt

 

(864

)

 

(2,274

Payments of Debt Issuance Costs

 

-

 

 

3

 

Net Cash Provided by (Used for) Financing Activities

$

(3,125

)

(2,163

 
Effect of Exchange Rate Changes on Cash and Cash Equivalents

 

44

 

 

336

 

Net Increase in Cash and Cash Equivalents

$

466

 

618

 

Cash and Cash Equivalents, Beginning of Period

 

3,606

 

 

4,432

 

Cash and Cash Equivalents, End of Period

$

4,072

 

5,050

 

 
Supplemental Information:
Cash Paid During the Period for:
Interest

$

751

 

810

 

Income Taxes, net of refunds

 

13

 

 

707

 

Non-Cash Transactions:
Operating Lease Obtained in Exchange for Operating Lease Liabilities

$

89

 

 

ASTRONOVA, INC.

Condensed Consolidated Statements of Cash Flow – Twelve Months

(In thousands)

(Unaudited)

 
Twelve Months Ended
January 31, 2026 January 31, 2025
Cash Flows from Operating Activities:
Net Income (Loss)

$

(2,376

)

(14,489

Adjustments to Reconcile Net Income (Loss) to Net Cash Provided by Operating Activities:
Depreciation and Amortization

 

4,804

 

 

4,780

 

Grant Income Included in Depreciation

 

330

 

 

159

 

Goodwill Impairment

 

297

 

 

13,403

 

Amortization of Debt Issuance Costs

 

43

 

 

30

 

Share-Based Compensation

 

2,310

 

 

1,378

 

Deferred Income Tax Provision (Benefit)

 

(1,312

)

 

874

 

Loss on Disposal of Fixed Assets

 

115

 

 

 

Changes in Assets and Liabilities:
Accounts Receivable

 

2,786

 

 

2,859

 

Inventories

 

5,909

 

 

1,616

 

Income Taxes

 

663

 

 

(904

Accounts Payable and Accrued Expenses

 

(1,125

)

 

(2,379

Deferred Revenue

 

(420

)

 

(1,520

Other

 

(286

)

 

(959

Net Cash Provided by Operating Activities

$

11,738

 

4,848

 

 
Cash Flows from Investing Activities:
Proceeds from Sale of Equipment

 

113

 

 

 

Purchases of Property, Plant and Equipment

 

(332

)

 

(1,165

Cash Paid for MTEX Acquisition, net of cash acquired

 

-

 

 

(19,109

Net Cash Used for Investing Activities

$

(219

)

(20,274

 
Cash Flows from Financing Activities:
Net Cash Proceeds from Employee Stock Option Plans

 

-

 

 

12

 

Net Cash Proceeds from Share Purchases under Employee Stock Purchase Plan

 

51

 

 

146

Für dich aus unserer Redaktion zusammengestellt

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.


Weitere Artikel des Autors

Themen im Trend